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The primary goal of this study was to test the hypothesis that
Oxalobacter colonization alters colonic oxalate transport
thereby reducing urinary oxalate excretion. In addition, we
examined the effects of intraluminal calcium on Oxalobacter
colonization and tested the hypothesis that endogenously
derived colonic oxalate could be degraded by lyophilized
Oxalobacter enzymes targeted to this segment of the
alimentary tract. Oxalate fluxes were measured across
short-circuited, in vitro preparations of proximal and distal
colon removed from Sprague–Dawley rats and placed in
Ussing chambers. For these studies, rats were colonized with
Oxalobacter either artificially or naturally, and urinary oxalate,
creatinine and calcium excretions were determined.
Colonized rats placed on various dietary treatment regimens
were used to evaluate the impact of calcium on Oxalobacter
colonization and whether exogenous or endogenous oxalate
influenced colonization. Hyperoxaluric rats with some degree
of renal insufficiency were also used to determine the effects
of administering encapsulated Oxalobacter lysate on colonic
oxalate transport and urinary oxalate excretion. We conclude
that in addition to its intraluminal oxalate-degrading
capacity, Oxalobacter interacts physiologically with colonic
mucosa by inducing enteric oxalate secretion/excretion
leading to reduced urinary excretion. Whether Oxalobacter,
or products of Oxalobacter, can therapeutically reduce
urinary oxalate excretion and influence stone disease
warrants further investigation in long-term studies in various
patient populations.
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In 1980, the discovery of the substrate-specific, oxalate-
degrading, gut resident bacteria, Oxalobacter formigenes,1
provided a new direction in the arena of oxalate stone disease
research that had been primarily focused on urinary oxalate
excretion and urinary crystallization. Clinical findings suggest
that there is a direct correlation between the complete
absence or decreased activity of luminal Oxalobacter and the
development of recurrent oxalate stone disease as well as the
hyperoxaluria associated with other conditions.2–9 Studies
have demonstrated a reduction in urinary oxalate excretion
when rats, fed oxalate in their diet, were either gavaged with
whole Oxalobacter cells10 or given encapsulated Oxalobacter
enzymes.2 This effect has been presumed to be solely due to
degradation of luminal oxalate by enzymes produced by the
bacteria leading to a reduction in the amount of oxalate
absorbed by the large intestine. We have proposed that, in
addition to luminal oxalate degradation, Oxalobacter may
also derive oxalate from systemic sources possibly by
initiating or enhancing enteric oxalate secretion. The notion
that intestinal transport of oxalate plays a role in oxalate
homeostasis is based upon a number of studies demonstrat-
ing the ability of intestinal epithelia to regulate the
magnitude and direction of oxalate transport.11
The goal of the present study was to determine whether
Oxalobacter colonization reduces urinary oxalate excretion by
altering colonic oxalate handling. We conclude that, in
addition to its intraluminal oxalate-degrading capacity,
Oxalobacter interacts physiologically with colonic mucosa
and induces enteric oxalate secretion leading to reduced
urinary oxalate excretion.
RESULTS
Artificially colonized rats have reduced urinary oxalate
excretion and support colonic oxalate secretion
Serum solute concentrations and urinary solute excretion in
rats artificially colonized with Oxalobacter were compared
with rats that were not colonized (Table 1). The results clearly
show that colonization was associated with a significantly
lower urinary oxalate excretion. Although serum oxalate was
within the normal range (5.1–16.6 mmol/l) in these rats12 and
not significantly different from controls, urinary oxalate
excretion was expectedly elevated because of administering
the oxalate-supplemented diet necessary for the colonization
http://www.kidney-international.org o r i g i n a l a r t i c l e
& 2006 International Society of Nephrology
Received 11 May 2005; revised 6 August 2005; accepted 5 October
2005; published online 11 January 2006
Correspondence: M Hatch, Department of Pathology, Immunology &
Laboratory Medicine, PO Box 100275, 1600 SW Archer Road, Gainesville,
Florida 32610, USA. E-mail: hatchma@ufl.edu
Kidney International (2006) 69, 691–698 691
procedure (basal excretion of oxalate before administering
the oxalate supplemented diet was 6.670.4 mmol/24 h in rats
designated for colonization (C) and 8.171.2 mmol/24 h in
rats assigned to the group not colonized (NC)). It is apparent
that short-term feeding (a total of 9 days) with the oxalate-
supplemented diet does not alter renal function in these rats
since serum creatinine, urinary creatinine excretion and
clearance were all normal.13 It is also notable that while
serum calcium homeostasis was maintained, urinary calcium
excretion was markedly reduced in both rat groups that was
also anticipated because of the low calcium (0.5%)/oxalate
(1.5%) ratio in the food (basal excretion of calcium before
administering the oxalate-supplemented, low calcium diet
was 70.2710.2 mmol/24 h in C rats and 68.176.4 mmol/24 h
in NC rats).
As shown in Figure 1, the distal colon of artificially
colonized rats supports a significant basal net secretory flux
of oxalate compared to net absorption in rats not colonized
and this alteration in transport occurred by way of a
significant reduction in Jms. For comparison purposes, the
unidirectional and net fluxes of oxalate across the distal colon
removed from non-colonized rats fed the standard Purina
chow 5001 are also presented. These results show that oxalate
fluxes in the distal colon were not affected by the short-term
feeding of the oxalate-supplemented diet as these are
comparable to animals fed the standard chow. In addition,
the electrical characteristics of these tissues were not altered
by either the diet or the colonization status of the animal.
We also evaluated oxalate transport across the proximal
colonic segment removed from these rats (data not shown),
which was not significantly changed by colonization or by
any of the treatments employed in this study. Consequently,
the data are not presented for each experimental series that
was conducted in parallel using this segment.
Naturally colonized rats have reduced urinary oxalate
excretion and support colonic oxalate secretion
The results presented in Table 2 provide a comparison of
serum solute concentrations and urinary solute excretion in
rats naturally colonized with Oxalobacter compared with rats
not colonized. Unlike the artificially colonized rats, the
naturally colonized rats have normal urinary oxalate excre-
tion because they were fed a maintenance diet of 0.5%
oxalate/0.5% calcium for 9 days before study and were found
Table 1 | Oxalate, calcium and creatinine concentrations in
serum and urine of rats artificially colonized with Oxalobacter
(C) compared with rats non-colonized (NC), both fed a diet
containing 1.5% oxalate/0.5% calcium for 9 days
Serum Excretion Clearance
Oxalate
NC 9.5971.39 20.6871.14 1.7370.13
C 8.3270.62 16.9270.75* 1.3770.22
Calcium
NC 2.5670.07 7.5570.86 2.0870.28
C 2.6570.05 11.9671.89 2.7570.32
Creatinine
NC 56.5072.86 80.5973.10 1.0070.06
C 57.0072.48 81.1474.12 0.9970.08
Serum oxalate and creatinine concentrations are given in mmol/l whereas serum
calcium concentration is given in mmol/l. Urinary excretion is given in mmol/24 h.
Renal clearance of oxalate and creatinine is given ml/min whereas calcium clearance
is given in ml/min. Values are means7s.e. for the mean of duplicate determinations
in five animals in each group. At the time of study, body weights in both groups
were similar (31077 g in NC and 31676 g in C).
C, colonization; NC, not colonized.
*A significant difference between groups is denoted by an asterisk, Po0.05.
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Figure 1 | Unidirectional and net transepithelial fluxes of oxalate
across isolated, short-circuited segments of the distal colon from
rats non-colonized (n¼ 10) and artificially colonized rats (n¼ 6)
fed a diet containing 1.5% oxalate/0.5% calcium for a period of 9
days. An asterisk indicates a significant difference between the
groups. Isc and transepithelial conductance (GT) were not affected by
colonization (Isc¼ 4.070.3 mEq/cm2/h and GT¼ 13.770.8/mS/cm2 in
non-colonized rats). For comparison, fluxes across the distal colon of
non-colonized rats (n¼ 7) fed the standard Purina 5001 chow
(contemporary controls) are presented. Isc and GT measured in the
distal colon of the latter group was 5.070.5 mEq/cm2/h and
11.370.8 mS/cm2.
Table 2 | Oxalate, calcium and creatinine concentrations in
serum and urine of rats naturally colonized with Oxalobacter
(C) compared with rats non-colonized (NC), both fed a diet
containing 0.5% oxalate/0.5% calcium for 9 days
Serum Excretion Clearance
Oxalate
NC 13.9572.08 8.3170.87 0.3970.05
C 13.5471.26 5.4170.53* 0.3270.04
Calcium
NC 2.4470.06 21.7573.84 6.1671.15
C 2.5270.05 25.7973.36 6.8971.06
Creatinine
NC 58.9075.88 54.0073.16 0.6770.07
C 57.9073.50 50.9772.43 0.6370.04
Serum oxalate and creatinine concentrations are given in mmol/l whereas serum
calcium concentration is given in mmol/l. Urinary excretion is given in mmol/24 h.
Renal clearance of oxalate and creatinine is given ml/min whereas calcium clearance
is given in ml/min. Values are means7s.e. for the mean of duplicate determinations
in 9 and 15 animals in each group, NC and C, respectively. At the time of study, body
weights in both groups were similar (235713 g in NC and 224713 g in C).
C, colonization; NC, not colonized.
*A significant difference between groups is denoted by an asterisk, Po0.05.
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to have normal serum oxalate concentrations. Again, the
results show that colonization is associated with a signifi-
cantly lower urinary oxalate excretion. The results also show
that these rats have normal renal function and normal serum
calcium concentrations. Similar to the artificially colonized
rats, a reduction in urinary calcium excretion, albeit less, is
observed in the naturally colonized rats because of the
calcium (0.5%)/oxalate (0.5%) ratio in the diet.
The results of the transport studies, presented in Figure 2,
confirm colonic secretion of oxalate occurs in naturally
colonized rats compared to a net absorptive flux in colonic
segments from rats that are not colonized fed the same diet or
fed the standard chow (see Figure 1). As in the previous
series, we observed that the electrical characteristics of these
tissues are not altered by either the diet or the colonization
status of the animal. Taken together, the results of these
studies with artificially and naturally colonized rats indicate
that urinary oxalate excretion can be regulated by Oxalo-
bacter-induced enteric oxalate secretion.
Intraluminal calcium content influences Oxalobacter
colonization
We directly addressed the question of whether intraluminal
calcium impacts Oxalobacter colonization and intestinal
oxalate transport. Artificially colonized rats were randomly
divided into three groups and each group was fed one of the
following diets for a 30-day period: (1) 0.5% oxalate/0.01%
calcium (xLow), (2) 0.5% oxalate/0.5% calcium (Low), and
(3) 0.5% oxalate/1.2% calcium (High). It is notable here that
the standard chow contains 0.95% calcium. In summary, the
results of the fecal analyses showed that only one of the three
groups of rats maintained colonization and that was the
group fed the xLow calcium diet (0.01%).
A comparison of serum and urinary oxalate, creatinine
and calcium in the three different groups is presented in
Table 3. The results show that all of the rats have normal
plasma oxalate and calcium concentrations as well as normal
renal function (creatinine clearance). Hyperoxaluria with
hypocalciuria was evident only in rats consuming the xLow
calcium diet, which is consistent with enhanced oxalate
availability and absorption in the upper parts of the intestinal
tract. As expected, hypercalciuria was only manifest in the
rats consuming the high calcium diet and urinary oxalate
excretion was normal in this group.
The results of the flux studies, comparing the xLow- and
High-calcium fed groups, are presented in Figure 3. Rats that
were fed the xLow calcium diet and remained colonized,
exhibited enteric oxalate secretion, whereas rats fed the high
calcium diet and lost colonization, exhibited net colonic
absorption. The group fed the 0.5% calcium diet (Low), that
also lost colonization, similarly exhibited net colonic
absorption of oxalate (data not shown).
Oxalobacter can derive oxalate from endogenous sources
The next question addressed was whether colonization can be
influenced by oxalate that is derived endogenously versus
exogenously. In previous studies, we had shown that in non-
colonized rats with a unilateral nephrectomy, ethylene glycol
(EG) treatment results in inducing net oxalate secretion
across the distal colon after 2 weeks.14 The experimental
design involved three unilateral nephrectomized rat groups
and each group was placed on one of the following regimens:
(1) 0.5% oxalate/0.5% calcium (Ox), (2) no oxalate/0.5%
calcium with 0.75% EG in the drinking water (EG) and (3)
0.5% oxalate/0.5% calcium with 0.75% EG in the drinking
water, (Oxþ EG).
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Figure 2 | Unidirectional and net transepithelial fluxes of oxalate
across isolated, short-circuited segments of the distal colon from
non-colonized rats (n¼ 8) and naturally colonized rats (n¼ 13)
fed a diet containing 0.5% oxalate/0.5% calcium for a period
of 9 days. An asterisk indicates a significant difference between
the groups. Isc and GT were not affected by colonization
(Isc¼ 3.870.3 mEq/cm2/h and GT¼ 9.870.6 mS/cm2 in NC rats)
or by the diet (compared with results of controls in Figure 1).
Table 3 | Oxalate, calcium, and creatinine concentrations in
serum and urine of rats artificially colonized with Oxalobacter
fed a diet containing either 0.5% oxalate/0.01% calcium
(xLow), 0.5% oxalate/0.5% calcium (Low), or 0.5% oxalate/
1.2% calcium (High) for 30 days
Serum Excretion Clearance
Oxalate
xLow 7.7871.77 101.8874.77* 18.6078.41*
Low 6.4771.67 8.4171.01 1.4870.43
High 11.0971.01 6.6971.10 0.4370.07
Calcium
xLow 2.5070.05 8.2370.91* 2.3170.27
Low 2.4970.03 64.57710.99 18.3473.18
High 2.8170.09 143.56727.26* 35.5776.82*
Creatinine
xLow 49.0071.00 128.7877.32 1.8270.12
Low 52.0072.00 99.5672.96 1.3570.08
High 54.0072.00 112.2176.75 1.4670.12
Serum oxalate and creatinine concentrations are given in mmol/l whereas serum
calcium concentration is given in mmol/l. Urinary excretion is given in mmol/24 h.
Renal clearance of oxalate and creatinine is given ml/min whereas calcium clearance
is given in ml/min. Values are means7s.e. for the mean of duplicate determinations
in seven animals in each group. At the time of study, body weights in all groups
were similar (36877 g in xLow, 35276 g in Low, and 35576 g in High).
*An asterisk denotes a significant difference between the group indicated and the
other two groups, Po0.05.
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Serum and urinary oxalate, creatinine and calcium levels
in the three different groups are presented in Table 4. Rats
given an exogenous source of oxalate (Ox) had normal serum
and urinary oxalate levels whereas proportional elevations in
both were observed in EG and in Oxþ EG rats, both of which
derived oxalate endogenously. Apart from urinary calcium
excretion, which was significantly lower in EG and in
Oxþ EG rats, all other serum and urinary parameters were
comparable among the three groups. As expected, renal
function was affected by all three treatment regimens in the
unilaterally nephrectomized rats as judged by significant
increases in serum creatinine compared to rats with two
kidneys intact (see Tables 1–3) or compared to unilaterally
nephrectomized rats not given EG (serum creatini-
ne¼ 49.2572.04 mM; creatinine clearance¼ 2.3570.16 ml/
min, n¼ 8).
As shown in Figure 4, all of the rats supported net oxalate
secretion across the distal colon and, importantly, all of the
rats were found to be colonized at the time the flux
experiments were conducted. Again, the electrical properties
of the tissues removed from the three groups (data not
shown) were comparable to the group fed standard chow (see
Figure 1) and not altered by any of the treatment regimens.
Hyperoxaluric rats treated with encapsulated O. formigenes
lysate have reduced urinary oxalate excretion and support
colonic oxalate secretion
We then tested the effects of a lysate preparation from
Oxalobacter by administering enteric-coated capsules, con-
taining the freeze-dried lysate, to unilateral nephrectomized
rats administered 0.75% EG. The experiment involved six rats
in each group, which were given either a placebo or the
encapsulated lyophilized lysate preparation, twice a day, for 5
days. At the end of this period, urine and blood were
collected and colonic tissues were removed for oxalate flux
studies.
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Figure 3 | Unidirectional and net transepithelial fluxes of oxalate
across isolated, short-circuited segments of the distal colon from
artificially colonized rats fed a diet containing 0.5% oxalate/
0.01% calcium (n¼ 7) or a diet containing 0.5% oxalate/1.2%
calcium (n¼ 7) for a period of 30 days. An asterisk indicates a
significant difference between the group fed 1.2% calcium and a
group of non-colonized rats fed the standard chow (comparison with
results in Figure 1 for non-colonized rats fed the standard chow
which contains 0.95% calcium). Isc and GT were not affected by
colonization (Isc¼ 4.570.3 mEq/cm2/h and GT¼ 11.070.4 mS/cm2 in
colonized rats fed 0.01% calcium) or by the calcium content of the
diet (compared with results of controls in Figure 1).
Table 4 | Oxalate, calcium, and creatinine concentrations in
serum and urine of unilaterally nephrectomized rats artifi-
cially colonized with Oxalobacter fed a diet containing either
0.5% oxalate/0.5% calcium (Ox), no oxalate/0.5% calcium
with ethylene glycol (EG), or 0.5% oxalate/0.5% calcium with
ethylene glycol (Ox+EG) for 14 days
Serum Excretion Clearance
Oxalate
Ox 9.1770.58* 11.7070.58 0.8970.08
EG 23.374.40 27.0075.60 0.8170.02
Ox+EG 45.0079.09 54.4077.40* 1.0470.26
Calcium
Ox 2.6970.05 62.90712.02* 16.1175.05
EG 2.3070.34 34.30711.9 18.0573.19
Ox+EG 2.3970.11 23.6076.10 8.1770.97
Creatinine
Ox 74.0071.00y 119.677.32 1.1370.08y
EG 90.30717.10y 89.30710.15 0.7570.18y
Ox+EG 110.00724.10y 103.4076.77 0.6670.18y
Serum oxalate and creatinine concentrations are given in mmol/l whereas serum
calcium concentration is given in mmol/l. Urinary excretion is given in mmol/24 h.
Renal clearance of oxalate and creatinine is given ml/min whereas calcium clearance
is given in ml/min. Values are means7s.e. for the mean of duplicate determinations
in animals in each group, Ox (n=5), EG (n=5) and Ox+EG (n=7), respectively. At the
time of study, body weights in all groups were similar (359715 g in Ox, 326713 g in
EG, and 35376 g in Ox+EG).
Ox, Oxalate; EG, ethylene glycol.
*An asterisk denotes a significant difference between the group indicated and the
other two groups, Po0.05.
yDenotes a significant difference in creatinine between the group indicated and the
controls fed the standard chow, Po0.05.
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Figure 4 | Unidirectional and net transepithelial fluxes of oxalate
across isolated, short-circuited segments of the distal colon from
artificially colonized rats with a unilateral nephrectomy given
different three treatment regimens for 14 days. (1) Diet contain-
ing 0.5% oxalate/0.5% calcium only (Ox, n¼ 6). (2) Diet containing no
oxalate/0.5% calcium and 0.75% ethylene glycol in the drinking water
(EG, n¼ 6). (3) Diet containing 0.5% oxalate/0.5% calcium and 0.75%
ethylene glycol in the drinking water (Oxþ EG, n¼ 6). There are no
significant differences among the groups in fluxes or electrical
characteristics. An asterisk indicates a significant difference when
comparisons are made between each group and the appropriate
group of non-colonized rats fed the standard chow (data provided for
distal colon in Figure 1).
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Owing to EG treatment, both groups of rats were
hyperoxaluric and hyperoxalemic (see Table 5); however, we
did find a 50% reduction in urinary oxalate in the lysate-
treated group compared to the placebo-treated group. The
degree of hyperoxaluria produced in all of these animals
resulted in a significant 25–30% reduction in renal function
(see Table 5, creatinine) compared to unilaterally nephrecto-
mized rats not given EG (plasma creatinine¼ 49.2572.04;
creatinine clearance¼ 2.3570.16 ml/min, n¼ 8) and the
lysate treatment had no effect on this. Finally, calcium
homeostasis in both groups was not affected by either EG or
by lysate treatment in this short-term experiment.
The results of the transport studies conducted in the two
groups of animals are presented in Figure 5. Whereas the
placebo-treated rats supported a small net absorptive flux of
oxalate, a significant colonic secretion of oxalate was induced
in the group treated with the encapsulated lysate. It is notable
that while tissue conductance was unchanged, an increase in
Isc was observed in the lysate-treated group, which can be
explained by concomitant induction of net chloride secretion
across these tissues (data not shown). These results are
significant because they suggest that the lysate has dual
actions, namely, induction of oxalate secretion across the
distal colon as well as enzymatic oxalate degradation.
Effect of Oxalobacter products on colonic oxalate transport
The effects of selected bacterial products on epithelial oxalate
transport were directly tested in a series of in vitro flux
experiments. The products of Oxalobacter included the
following: (1) washed, whole cells, (2) washed cell membrane
fragments and (3) lysates from different strains. Distal
colonic tissues removed from rats, not colonized and fed
the standard chow, were used in these experiments and, as
shown in Figure 1, these tissues characteristically support net
absorption of oxalate. Initial experiments quickly revealed
that although Oxalobacter is described as an obligative
anaerobe,15 we noted a significant and rapid degradation of
oxalate in the standard aerated (95% O2/5% CO2) buffers
bathing the mucosal side of the colonic preparation following
the addition of the bacterial cells. Heat-treatment, by
plunging a tube containing the bacterial cell preparation
into boiling water for 5 min, eradicated this degradative
activity and the experiments were subsequently conducted
using whole cells (6 mg wet weight/ml of bathing solution)
treated in this way. Oxalate degradation was not an issue with
the cell membrane fragments that were simply washed 3
times in the standard buffer before adding 6 mg wet weight/
ml of buffer bathing the mucosal side of the tissue. The
addition of whole, heat-treated Oxalobacter cells or cell
membrane fragments to the mucosal side of the distal colon
caused no significant changes in the unidirectional fluxes of
oxalate (data not shown).
The final experimental series examined the effects of lysate
preparations (final protein concentration 0.54 mg/ml of
mucosal bathing solution) from various strains of Oxalobac-
ter cells on oxalate transport in the distal colon. Six
preparations were tested including OxB, HC-1, VA3, OxCr,
OxWR and a non-pathogenic strain of Escherichia coli for
comparison. Once again, because the native bacterial lysate
rapidly degraded oxalate in the Ussing chamber, it was
necessary to heat-treat the lysate solution for 1 min as
described above for the whole cells before addition to the
mucosal side of the tissue. The results showed that none of
the lysates altered oxalate transport or the electrical proper-
ties of the tissues (data not shown).
Table 5 | Oxalate, calcium and creatinine concentrations in
serum and urine of unilaterally nephrectomized rats fed the
standard chow and given 0.75% ethylene glycol combined
with either placebo or encapsulated lysate for a 5-day period
Serum Excretion Clearance
Oxalate
Placebo 46.18711.59 102.68711.42 1.5170.17
Lysate 57.9378.91 57.5677.99* 0.7270.44
Calcium
Placebo 2.4970.05 119.18715.65 31.8674.84
Lysate 2.3670.04 107.07716.21 33.0675.23
Creatinine
Placebo 84.1773.15 214.00710.31 1.7870.11
Lysate 78.8074.25 175.98715.77 1.5970.15
Serum oxalate and creatinine concentrations are given in mmol/l whereas serum
calcium concentration is given in mmol/l. Urinary excretion is given in mmol/24 h.
Renal clearance of oxalate and creatinine is given ml/min whereas calcium clearance
is given in ml/min. Values are means7s.e. for the mean of duplicate determinations
in six animals in each group. At the time of study, body weights in both groups were
similar (34773 g in placebo and 32675 g in lysate).
*A significant difference between groups is denoted by an asterisk, Po0.05.
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Figure 5 | Unidirectional and net transepithelial fluxes of oxalate
across isolated, short-circuited segments of the distal colon from
unilaterally nephrectomized rats (not colonized) fed standard
chow and provided 0.75% ethylene glycol for 5 days. Capsules
containing Oxalobacter lysate (n¼ 6), or placebo capsules (n¼ 9)
were administered twice on each day. An asterisk indicates a
significant difference between the groups. Isc was higher in the
lysate-treated group (4.370.6 mEq/cm2/h) compared to placebo
(3.070.2mEq/cm2/h). GT in the experimental groups was not
significantly different from each other or from control rats fed
standard chow (data provided in Figure 1).
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DISCUSSION
Compelling evidence has emerged from a number of human
and animal studies4–9,11 suggesting that Oxalobacter regulates
intraluminal oxalate availability by degrading dietary oxalate
thereby reducing intestinal oxalate absorption and urinary
excretion. We have proposed that, in addition to oxalate
degradation, Oxalobacter may also interact physiologically
with intestinal mucosa. The results obtained are significant
because they show support for the notions that (i)
Oxalobacter can derive oxalate from systemic sources by
initiating colonic oxalate secretion and (ii) the balance
between renal and enteric excretion of endogenously derived
oxalate may effect a change in urinary oxalate excretion.
Colonization with Oxalobacter
The results of the studies examining intestinal oxalate
transport and urinary oxalate excretion in Oxalobacter-
colonized rats were consistent regardless of whether the rats
were colonized artificially or naturally. Clearly, the presence
of the mucosal bacteria was associated with a reversal in basal
oxalate absorption to net secretion in the distal colon and
urinary oxalate excretion was significantly reduced. As the
reduction in urinary oxalate excretion observed was not
apparently associated with a change in either renal function
(as judged by serum creatinine and creatinine clearance) or in
renal calcium handling, we suggest that this advantageous
effect was mediated enterically. Oxalobacter degradation of
exogenous oxalate in the diet coupled with the induction of
enteric oxalate secretion provides the simplest explanation
for these results.
The present study also demonstrated that the maintenance
of Oxalobacter colonization appears to be exquisitely sensitive
to the balance between intraluminal calcium and oxalate
availability. Daniel et al.16 found that the rat’s diet had to
contain at least 3% oxalate in order to sustain Oxalobacter
colonization and Sidhu et al.10 observed that when oxalate is
removed from the diet, artificially colonized rats lose
colonization within 5 days. In our study, with diets contain-
ing 0.5% oxalate, colonization was only supported when the
calcium content was much lower (0.01%) than that of
oxalate. Rats, that were initially colonized and subsequently
fed the oxalate-supplemented diet containing either 0.5 or
1.2% calcium, had lost colonization in the same time period.
It is notable, however, that colonization in this one group
(Ox) was associated with the induction of enteric oxalate
secretion whereas intestinal oxalate handling in the other two
groups was comparable to that of non-colonized rats. It is
also notable that the group that remained colonized was
severely hyperoxaluric because of the dietary oxalate load,
which, more than likely, greatly overwhelmed the degradative
capacity of the freshly established microbial population.
Endogenous versus exogenous sources of oxalate
Although it was clear that Oxalobacter colonization was
dependent on an exogenous source of bioavailable oxalate in
the diet, it was also demonstrated here that endogenously
derived oxalate, from EG metabolism, sustained colonization
under certain experimental conditions. In a previous study,
we had shown that in non-colonized rats with a unilateral
nephrectomy, EG administration results in inducing net
oxalate secretion across the distal colon after 14 days of
treatment.14 Under all of the conditions tested, which
included rats given either an exogenous or endogenous
oxalate load alone, or both together, the animals remained
colonized for at least 14 days. Further, it was revealed from
the flux studies that the three groups had, in common, a
significant enteric oxalate excretion induced by varying
degrees of renal insufficiency. In an earlier series (see Table 3),
the same dietary regimen (0.5% oxalate/0.5% calcium) was
administered to colonized rats with normal renal function
but these rats lost colonization and consequently exhibited
normal colonic oxalate handling. Although the rats deriving
oxalate endogenously were colonized, which was the specific
question addressed by this study, they were also hyper-
oxalemic and hyperoxaluric, and renal function was compro-
mised. The absence of an anticipated or possible protective
effect of colonization against these insults would indicate
that, again perhaps, the oxalate load greatly overwhelmed the
degradative capacity of the newly established microbial
population. Nonetheless, these results are significant because
they demonstrate that Oxalobacter can utilize endogenously
derived substrate.
Treatment of rats with encapsulated Oxalobacter lysate
Treatment of rats with an encapsulated, freeze-dried
preparation of Oxalobacter was shown previously to reduce
urinary oxalate excretion2 and we confirmed that observation
here. However, in contrast to the previous study where rats
were provided an exogenous source of oxalate in the diet, the
rats here derived oxalate endogenously from EG metabolism.
A novel finding of the present study is that Oxalobacter lysate
induced colonic oxalate secretion. This induction of oxalate
secretion in the lysate-treated group suggests that the lysate
has dual actions, namely a secretagogue action in addition to
enzyme degradation of luminal oxalate. Importantly, the
effects on colonic oxalate transport coupled with the redu-
ction in urinary oxalate excretion indicate that the balance
between renal and enteric oxalate excretion could be manipulated
by a product of the bacteria.
Oxalobacter products and colonic oxalate transport
We initially hypothesized that Oxalobacter may have the
strategic ability to locally modulate epithelial oxalate
transport and induce colonic oxalate secretion. The results
thus far would strongly suggest that this is the case. However,
from our results of the final experiments testing the effects of
Oxalobacter cells, and cell membranes, it would be difficult to
defend the notion that a cell wall component of the
bacterium interacts with the enterocyte or some submucosal
immune element and induces secretion. Neither the whole
cells nor the cell membrane fragments induced colonic
oxalate secretion. However, the observation that colonic
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mucosa from colonized rats consistently secretes oxalate
supports the original hypothesis, and the results of the flux
studies using the heat-treated whole cells are not inconsistent
with this. In the oxygenated Ussing chamber environment, it
is highly unlikely that the heat-treated Oxalobacter cells will
either grow or produce the purported secretagogue. The
results demonstrating that feeding the encapsulated Oxalo-
bacter lysate induced colonic oxalate secretion in vivo
(Figure 5) suggest that the bacteria elaborates a secretagogue
and this may be the basis for a survival strategy, especially
when substrate is limiting. The fact that the in vitro addition
of lysates from different strains of Oxalobacter had no effect
on oxalate transport may simply be due to the heat treatment
used to eradicate the inherent enzymatic activity of the lysate.
It is possible that heat treatment also abolished the
secretagogue activity that was evident in vivo (Figure 5).
In conclusion, these studies provide evidence that there is
a physiological interaction between Oxalobacter and the
transporting colonic epithelium, which results in a stimula-
tion of enteric oxalate elimination and a concomitant
reduction in urinary oxalate excretion. However, the
definitive role of Oxalobacter or its potential as a probiotic
in reducing oxalate stone disease in humans needs to be
addressed.
MATERIALS AND METHODS
Animals
All animal experimentation described in this paper was conducted
in accordance with the University of Florida and the NIH Guide for
the Care and Use of Laboratory Animals. Male Sprague–Dawley rats
(200–375 g) used in the following studies had free access to drinking
water and Purina rat chow 5001 for at least a week before initiating
one of the oxalate-supplemented diets described. As laboratory rats
are not normally colonized with Oxalobacter sp., colonization of a
number of rats was necessary as described.17 For two experimental
series, hyperoxaluric rats with some degree of renal insufficiency
were produced by performing a unilateral nephrectomy on each
animal followed by ethylene glycol treatment (0.75%, administered
in the drinking water) as previously described.14 At the end of the
specified treatment, before collecting blood and colonic tissues for
the flux studies, urine from each rat was collected over a period of
24 h into vessels containing 3.0 ml of 3.5 N HCl. The animals were
killed by an intraperitoneal injection of sodium pentobarbital
(150 mg/kg body weight) and promptly exsanguinated by cardiac
puncture. The blood was handled immediately with the appropriate
precautions to prevent oxalogenesis and oxalate was measured in the
serum and urine using our routine assay procedure.18 Creatinine
and calcium were determined in samples using the Sigma kit assay
555A and Sigma kit assay 587-A, respectively (Sigma Chemical Co.,
St Louis, M, USA).
Oxalobacter colonization studies
Rats were artificially colonized as previously described2 by
esophageal gavage of a 1.5 ml inoculum of 20 108 bacteria from
a 24-h culture of a wild rat strain of O. formigenes (OxWR, wild-rat
strain). Rats designated as non-colonized controls were gavaged
with the same volume of sterile culture media. Two or three days
later, feces was collected for the detection of Oxalobacter and,
following confirmation of colonization, 24-h urine collections were
made on the ninth day immediately before the rats were killed for
the transport studies. In addition, fecal samples collected directly
from the colonic lumen on the day of study were also tested for the
presence/activity of Oxalobacter.
The procedure for producing naturally colonized rats was
recently described in detail.17 Briefly, timed-pregnant, non-colo-
nized female rats (e12) were artificially colonized as above and
maintained on an oxalate-supplemented diet until the pups were
born. At weaning, the newborn rats were placed on the low calcium
(0.5%) diet supplemented with 0.5% oxalate. Fecal analysis showed
that the newborn rats maintained colonization until the flux studies
were conducted approximately 5 weeks after weaning.
Oxalobacter detection in feces
The presence of Oxalobacter in the feces was determined either by
anaerobic culture or by DNA analyses. In the former method,
approximately 20 mg of feces was inoculated into anaerobically
sealed vials containing medium B15 with 20 mM oxalate. After
incubation for 1 week, loss of oxalate in the media provided
confirmation of colonization. Additionally, bacterial DNA was
prepared from fecal samples as previously described19 using
QIAamp DNA Stool Kit (Qiagen, Inc., Valencia). The isolated
DNA was used as the template in polymerase chain reaction
amplification with primers specific for the oxc gene of O. formigenes.
All polymerase chain reaction products were verified by Southern
blot analysis with hybridization to internal probes, either a genus-
specific probe for Oxalobacter or a subgroup-specific probe for
Oxalobacter Group I (OxWR) strain.20
Preparation of Oxalobacter cells, lysate and cell membranes
O. formigenes strains. OxB isolated from sheep rumen, OxCr
isolated from white rat cecum, HC-1 and VA3 isolated from human
feces, and OxWR isolated from wild rat cecum were grown on
medium B15 except the oxalate concentration was 0.05 M for strains
OxCR and VA3 and 0.1 for all other strains. A non-pathogenic strain
of E. coli, strain American Type Culture Collection (ATCC) 47076,
was grown aerobically in a stirred flask in trypticase soy broth. Cells
harvested by centrifugation, suspended in buffer (KH2PO4 0.1 M, pH
7.2; dithiothreitol, 1 mM; MgCl2  6H2O, 10 mM; and thiamin
pyrophosphate, 1 mM) were passed through a French Pressure Cell
(American Instrument Co., Silver Spring, MD) at 20 000 psi. Cell
lysate was the supernatant after centrifugation (11 000 g, 41C, for
10 min). Cell membranes were similarly prepared except the buffer
contained KH2PO4 0.1 M, pH 7.2, dithiothreitol, 1 mM and
phenylmethylsulfonyl fluoride, 0.5 mM. The pressure cell effluent
was incubated for 30 min at room temperature after addition of:
MgSO4 to a final concentration of 4 mM, and 20–50 mg of crystalline
DNAase I. Cell debris was precipitated by three successive 10 min
centrifugations at 11 000 g and cell membranes were subsequently
precipitated at 138 000 g, 41C, for 60 min. Tests of the effects of
whole cells and cell membranes on colonic oxalate transport across
in vitro tissue preparations in the Ussing chamber were made with
strain OxB cells and cell membrane fragments that had been washed
3 times in large volumes of the standard flux buffer.
Gelatin capsules (size 9, Torpac Inc., Fairfield, NJ, USA) that
contained freeze-dried lysate of strain OxB, Oxalyl CoA, and
thiamine pyrophosphate (at a ratio of 8:1:1) were coated with
Eudragit L 100–55 (Huls America Inc., Rohm America Inc.,
Piscatway, NJ, USA) to protect capsule contents during passage
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through the acidic upper alimentary tract. Each capsule contained
approximately 15 mg of the active enzyme–cofactor mixture and this
mixture had an oxalate degrading activity of 0.024 mmol/min/mg
protein. An intragastric needle was used to deliver the capsules twice
a day for a 5-day period. Placebo-treated rats received Eudragit-
coated empty capsules. Protein was measured with the Pierce BCA
protein Assay kit (Rockford, IL, USA) and oxalate degrading activity
was determined by the method of Baetz and Allison.21
Transport studies
Immediately following killing and exsanguination of the rats, the
proximal and distal colonic segments were removed and prepared
for the 14C-oxalate flux studies in the Ussing chambers as previously
described.14 The magnitude and direction of the net flux (JNet) was
determined by calculating the difference between two unidirectional
fluxes (mucosal to serosal, Jms and serosal to mucosal, Jsm) measured
at 15 min intervals for a control period of 45 min (Per I), under
short-circuit conditions. In one series, Per I was followed by a
second 45 min flux period (Per II) in order to determine the effects
of Oxalobacter cells, cell membranes and lysates on oxalate transport
across tissues in vitro. The unidirectional tracer fluxes were
determined on matched tissues (GTp20%). The flux results
presented in the figures are given for ‘n’, which is the number of
matched tissue pairs. The electrical parameters of the tissue were
also recorded at 15 min intervals throughout the entire experiment.
Tissue conductance (GT, mS/cm
2) was calculated as the ratio of the
open-circuit potential (mV) to the short-circuit current (Isc, mA/
cm2).
Statistical analyses
Statistical analysis of the data derived from these experiments was
performed by using a one-way analysis of variance followed by
Bonferroni’s t-test for multiple comparisons. A paired or unpaired
t-test was used for the comparison of two means. Differences were
considered significant if Pp0.05.
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